Drawing for ABRELLODY

USPTO serial 88007986

ABRELLODY

Reviewed by CopyMark Law Group

Status 605
Filing date
Status date
Registration date
Examiner
BEVERLY, JOSETTE MICHELLE
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ABRELLODY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, liver disorders, erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations and smoking cessation preparations; vaccines for human useABANDONED

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 2, 2019MAB5ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION
Apr 2, 2019ABN5ABANDONMENT - AFTER PUBLICATION
Apr 1, 2019EXARTEAS EXPRESS ABANDONMENT RECEIVED
Dec 18, 2018NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 23, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 23, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 3, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 19, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Sep 19, 2018DOCKASSIGNED TO EXAMINER
Jun 26, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 23, 2018NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance